Bionovo initiates Menerba Phase 3 trial in menopausal hot flashes

[News]

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that the first patient has now been randomized and will begin dosing in the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerba (MF101) among a cohort of postmenopausal women for the treatment of menopausal hot flashes.

More... (http://www.news-medical.net/news/20111117/Bionovo-initiates-Menerba-Phase-3-trial-in-menopausal-hot-flashes.aspx)